CryoStasis Participating in the J.P. Morgan Biotech Showcase 2025

We are thrilled to announce that CryoStasis will be presenting at the Biotech Showcase 2025, held in conjunction with the J.P. Morgan Healthcare Conference, from January 13–17, 2025 in San Francisco, CA.

The Biotech Showcase is a premier event in the healthcare and life sciences industry, bringing together advanced therapy developers, tools and technology platforms together with a global audience of investors, partners, and thought leaders.

At CryoStasis, we are redefining biopreservation for the cell and gene therapy sector. Keith Millar, CEO, will share how inducing stasis (hibernation) using our Subzero Unfrozen platform is helping ensure scalable fill/finish, consistent viability, recovery, and potency from bioreactor to bedside for allogeneic cell therapies.

🔹 Presentation Details:
📅 Date: Tuesday, January 14th
🕒 Time: 2:15 – 2:45pm PST
📍 Location: Biotech Showcase, Hilton San Francisco, Union Square -- Franciscan B, Ballroom Level.

We are excited to highlight our recent advancements, including the promising results from our Early Adopter Program and Investigator Initiated Study Program, which have garnered significant interest among leading biotech and pharmaceutical companies.

Whether you’re attending the conference or happen to be in the San Francisco area, we invite you to connect with us to explore how CryoStasis can revolutionize your biopreservation processes.

📧 For more information or to schedule a meeting, please contact us at kmillar@cryostasis.ca.

We look forward to seeing you at the Biotech Showcase!

#CryoStasis #JPM2025 #BiotechShowcase #CellTherapy #Cryopreservation #Innovation